Literature DB >> 7728221

Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease.

Y Tatebayashi1, M Takeda, Y Kashiwagi, M Okochi, T Kurumadani, A Sekiyama, G Kanayama, S Hariguchi, T Nishimura.   

Abstract

Change in calcium response was studied to clarify the pathological process of Alzheimer's disease (AD). Cultured fibroblasts from patients with familial Alzheimer's disease (FAD; n = 6), sporadic Alzheimer's disease (SAD; n = 4), and age-matched healthy control subjects (n = 4) were studied with an ACAS Interactive Laser Cytometer (ACAS-470). Fibroblasts from two independent families with FAD (OS-1, and OS-2 families) showed a suppressed calcium response after stimulation by 100 nM bradykinin (BK) 100 nM vasopressin (VP) or 10% FCS in Ca(2+)-free condition compared with control fibroblasts at 48 h after plating. However, on the 7th day after plating, the abnormal calcium response was no longer observed. The height of the calcium peak showed periodic variation, indicating a relationship of calcium response with the cell cycle. When fibroblasts from OS-1 and OS-2 families were arrested in S phase, they showed a significantly suppressed calcium peak after BK stimulation. However, when those fibroblasts were arrested in other phases, they showed the same calcium peak as the other cells. The suppression of calcium response in S phase was indistinguishable from the calcium suppression induced by A23187 administration. Since Hardy type mutation on amyloid precursor protein gene is found in the OS-1 family, the observed abnormalities in calcium response might be related with pathological processing of amyloid precursor protein in AD. The reported abnormal calcium response, which is observed most obviously in fibroblasts in S phase, may indicate participation of the cell-cycle-dependent process in the pathology of AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728221     DOI: 10.1159/000106916

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  8 in total

1.  Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer's disease patients.

Authors:  Fernando Bartolomé; Ursula Muñoz; Noemí Esteras; Carolina Alquezar; Andrea Collado; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Cell Mol Life Sci       Date:  2010-07-08       Impact factor: 9.261

Review 2.  Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells.

Authors:  R Etcheberrigaray; S Bhagavan
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

3.  Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

4.  Pharmacological and genetic reversal of age-dependent cognitive deficits attributable to decreased presenilin function.

Authors:  Sean M J McBride; Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; David A Liebelt; David Ferreiro; Richard J Choi; Paul Hinchey; Maria Kollaros; Allison M Terlizzi; Neal J Ferrick; Eric Koenigsberg; Rebecca L Rudominer; Ai Sumida; Stephanie Chiorean; Kathleen K Siwicki; Hanh T Nguyen; Mark E Fortini; Thomas V McDonald; Thomas A Jongens
Journal:  J Neurosci       Date:  2010-07-14       Impact factor: 6.167

5.  Effect of ginkgolide K on calcium channel activity in Alzheimer's disease.

Authors:  Hongbin Liu; Qinyun Li; Xiaodan Zhang; Yun Shi; Jinyi Li
Journal:  Exp Ther Med       Date:  2022-05-05       Impact factor: 2.751

Review 6.  The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease.

Authors:  Antonio Currais; Tibor Hortobágyi; Salvador Soriano
Journal:  Aging (Albany NY)       Date:  2009-04-28       Impact factor: 5.682

7.  Distinct regulation of cell cycle and survival in lymphocytes from patients with Alzheimer's disease and amyotrophic lateral sclerosis.

Authors:  Fernando Bartolomé; Ursula Muñoz; Noemí Esteras; Jesús Esteban; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

8.  Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease.

Authors:  Noemí Esteras; Carolina Alquézar; Ana de la Encarnación; Alberto Villarejo; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Alzheimers Res Ther       Date:  2013-11-07       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.